Search

everythinglearnresearchcommunity

for

Search:↓

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Topical 1% sildenafil is not recommended for treating alopecia areata in children.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

SER120 nasal spray effectively reduces nighttime urination and is safe for patients.

Public health decisions should rely on independent trials, not biased literature.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Platelet-rich plasma does not improve recovery after Achilles tendon surgery.

Clinical trials for hair loss in the USA show differences in participation among different races and ethnic groups.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Both photobiomodulation and low-frequency treatments effectively reduce body measurements.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

The new cream is safe and effective for mild to moderate atopic dermatitis.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.